Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2026 -5.62M
June 30, 2026 -7.244M
March 31, 2026 -8.078M
December 31, 2025 -4.878M
September 30, 2025 -3.616M
June 30, 2025 -5.539M
March 31, 2025 -4.886M
December 31, 2024 -6.346M
September 30, 2024 -5.787M
June 30, 2024 -5.176M
March 31, 2024 -5.783M
December 31, 2023 -6.019M
September 30, 2023 -5.037M
June 30, 2023 -6.268M
March 31, 2023 -11.24M
December 31, 2022 -8.303M
September 30, 2022 -5.48M
June 30, 2022 -7.062M
March 31, 2022 21.90M
December 31, 2021 -5.873M
September 30, 2021 -4.848M
June 30, 2021 -5.416M
March 31, 2021 -7.424M
December 31, 2020 -5.641M
September 30, 2020 -4.847M
Date Value
June 30, 2020 -4.239M
March 31, 2020 -5.026M
December 31, 2019 -5.523M
September 30, 2019 -7.443M
June 30, 2019 -9.667M
March 31, 2019 -9.314M
December 31, 2018 -5.812M
September 30, 2018 -7.332M
June 30, 2018 -7.40M
March 31, 2018 -10.34M
December 31, 2017 -5.675M
September 30, 2017 -7.681M
June 30, 2017 -9.063M
March 31, 2017 -8.098M
December 31, 2016 -8.852M
September 30, 2016 -8.915M
June 30, 2016 -10.25M
March 31, 2016 -14.31M
December 31, 2015 -13.95M
September 30, 2015 -11.56M
June 30, 2015 -9.967M
March 31, 2015 -9.069M
December 31, 2014 -9.110M
September 30, 2014 -8.609M
June 30, 2014 -10.78M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Curis, Inc. -5.749M
Armata Pharmaceuticals, Inc. -5.516M
Voyager Therapeutics, Inc. -19.67M
Black Diamond Therapeutics, Inc. -8.338M
Invivyd, Inc. -32.11M